FDA Inspection 1219059 — Creative Testing Solutions

Creative Testing Solutions — FEI 3002580251

The FDA completed an inspection of Creative Testing Solutions on August 25, 2023 in Bedford, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 25, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Bedford, TX (United States)